As a ligand of Wnt signaling pathway, wnt16 is related to bone mineral density, cortical thickness, bone strength, and fracture risk, and this molecule might be an attractive target for pharmacologic intervention in treating osteoporosis [7,8,9,10]. This evidence concerns the gene WNT16 and osteoporosis.